DEVIN WEIDMAN: Open Payments
NPI 1669584157 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,186 in 46 payments from 11 companies in 2025. Trend: 2023 $258 · 2024 $1,507 · 2025 $3,186
Consulting: $2,338Food & beverage: $848
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $2,368 |
| Amgen Inc. | 15 | $256 |
| Novartis Pharmaceuticals Corporation | 15 | $247 |
| ABBVIE INC. | 5 | $114 |
| PFIZER INC. | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| UCB, Inc. | 1 | $29 |
| Radius Health, Inc. | 1 | $29 |
| CSL Behring | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: COSENTYX, EVENITY, KRYSTEXXA, XELJANZ, SKYRIZI, HUMIRA, OFEV, Bimzelx.
Industry payments across FL — which companies pay providers there.
